81506 Endoscopic assay seven anal
Also known as: diabetes risk profile, type 2 diabetes prediction
Endocrinology (type 2 diabetes risk) assay using seven genetic and biochemical analyses.
In Plain Language
genetic and blood test for diabetes risk
Clinical Context
Assessment of type 2 diabetes mellitus risk using genetic markers and biochemical factors for early identification of at-risk individuals.
RVU Information
CPT 81506 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81506?
CPT 81506 (Endoscopic assay seven anal) is a Pathology & Lab code. Endocrinology (type 2 diabetes risk) assay using seven genetic and biochemical analyses.
Who uses CPT code 81506?
CPT 81506 is used by endocrinology, molecular pathology, pathology. Assessment of type 2 diabetes mellitus risk using genetic markers and biochemical factors for early identification of at-risk individuals.
When is CPT 81506 used?
Assessment of type 2 diabetes mellitus risk using genetic markers and biochemical factors for early identification of at-risk individuals.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.